CORC  > 暨南大学
CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/beta-catenin pathway
Cao, Ting[1,4]; Xiao, Tian[1]; Huang, Guanqun[1]; Xu, Yafei[1]; Zhu, Joe Jiang[1]; Wang, Kaixin[5]; Ye, Wencai[4]; Guan, Hong[3]; He, Jinsong[2]; Zheng, Duo[1]
2017
卷号8期号:49页码:84917
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4746746
专题暨南大学
作者单位1.[1]Shenzhen Univ, Dept Cell Biol & Genet, Hlth Sci Ctr, Shenzhen 518060, Guangdong, Peoples R China
2.[2]Shenzhen Univ, Peoples Hosp Shenzhen 2, Affiliated Hosp 1, Dept Breast Surg, Shenzhen 518035, Guangdong, Peoples R China
3.[3]Shenzhen Univ, Affiliated Hosp 1, Peoples Hosp Shenzhen 2, Dept Pathol, Shenzhen 518035, Guangdong, Peoples R China
4.[4]Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituent, Guangzhou 510632, Guangdong, Peoples R China
5.[5]Shenzhen Nanshan Peoples Hosp, Dept Pathol, Shenzhen 518052, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Cao, Ting[1,4],Xiao, Tian[1],Huang, Guanqun[1],et al. CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/beta-catenin pathway[J],2017,8(49):84917.
APA Cao, Ting[1,4].,Xiao, Tian[1].,Huang, Guanqun[1].,Xu, Yafei[1].,Zhu, Joe Jiang[1].,...&Zheng, Duo[1].(2017).CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/beta-catenin pathway.,8(49),84917.
MLA Cao, Ting[1,4],et al."CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/beta-catenin pathway".8.49(2017):84917.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace